---

Congress and the Food and Drug Administration should act to protect an important pathway for timely approval of cheaper generic versions of brand-name drugs.
      

Source: The Commonwealth Fund: Blog - October 19, 2021 Category: International Medicine & Public Health Authors: Bryan Walsh Source Type: blogs